about
Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH)Expression of phosphoinositide-specific phospholipase C isoforms in native endothelial cellsMolecular imaging of the human pulmonary vascular endothelium in pulmonary hypertension: a phase II safety and proof of principle trial.Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.The research on endothelial function in women and men at risk for cardiovascular disease (REWARD) study: methodology.Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure.The endothelin system in pulmonary hypertension.Relative associations between depression and anxiety on adverse cardiovascular events: does a history of coronary artery disease matter? A prospective observational studyDiscovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.Demographics, treatment and outcome of acute coronary syndromes: 17 years of experience in a specialized cardiac centre.Evaluation of pulmonary perfusion by SPECT imaging using an endothelial cell tracer in supine humans and dogs.Endothelin-3-dependent pulmonary vasoconstriction in monocrotaline-induced pulmonary arterial hypertension.Cellular and molecular basis of pulmonary arterial hypertension.Absence of association between infectious agents and endothelial function in healthy young men.Lung capillary injury and repair in left heart disease: a new target for therapy?Evaluation of a Web-Based Tailored Nursing Intervention (TAVIE en m@rche) Aimed at Increasing Walking After an Acute Coronary Syndrome: A Multicenter Randomized Controlled Trial Protocol.Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases.Endothelial and Epithelial Cell Transition to a Mesenchymal Phenotype Was Delineated by Nestin Expression.Use of adrenomedullin derivatives for molecular imaging of pulmonary circulation.Role of endothelin receptors on basal and endothelin-1-stimulated lung myofibroblast proliferation.Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure.Molecular imaging of the pulmonary circulation in health and disease.Association between clinical depression and endothelial function measured by forearm hyperemic reactivity.Nitrates in congestive heart failure.Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials.Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.Evaluation of luminal endothelin-converting enzyme activity in the pulmonary and coronary circulations.Pulmonary production of osteopontin in humans: effects of left ventricular systolic dysfunction and cardiopulmonary bypass.Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide.Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging.Downregulation of the endothelin system of lung myofibroblasts in congestive heart failure.Molecular imaging of monocrotaline-induced pulmonary vascular disease with radiolabeled linear adrenomedullin.Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension.Increased endothelin levels in congestive heart failure: does it come from the lungs? Does it matter?Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice.A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84.Positive and Negative Affect Is Related to Experiencing Chest Pain During Exercise-Induced Myocardial Ischemia.Cardiopulmonary bypass is associated with altered vascular reactivity of isolated pulmonary artery in a porcine model: therapeutic potential of inhaled tezosentan.Resident nestin+ neural-like cells and fibers are detected in normal and damaged rat myocardium.
P50
Q26747747-976BACB3-7118-4826-BE55-6F03194581E6Q28546212-2DC89131-80B6-4EB4-BEF3-92A02018C7D0Q30851205-A4EF67C0-C2A8-4D82-8D35-7D03FB4A71F1Q31942397-8ECBA931-301D-49BE-AB2A-38172A6EFDB8Q33989516-DC059469-E260-4A2F-8A21-DA2C00877245Q34089553-2B494093-35CA-477A-9BE6-59CE9F042D98Q35168404-DF544438-DA87-407C-B912-31B1429FE781Q36374168-994187E4-91DB-4670-8F85-0C39C69C4138Q36781030-B0179208-7678-4398-B9D2-FC8606A10BCBQ36883383-87390F1B-AADD-4097-9A49-9D84E7779D41Q36942458-53E1E4F8-DF1F-4EC5-9618-05D1A8EF350EQ36980863-EBB7149B-281F-499F-9DEA-2A3F2616B0F6Q37465320-B596EF1B-A770-49AD-A618-15F7BEC887F4Q37869631-D10D18EF-A7BA-4EEC-8903-4FC21504EA47Q38200142-CEEDE649-6A8B-486C-8EE9-45D0376DE8F1Q38374774-389FDB15-DA56-40D4-AC1D-5DB10564F4CBQ38403596-FE4D15E5-8E63-46E6-AA52-65AF19DF5563Q38404272-4B93B33E-5780-4C00-B88B-3A8B65FC3EF5Q38819080-ED1B30CF-3654-447C-B077-B3549F0936CBQ39928445-23A4F7FE-3A4E-4ADA-BF92-E7B3EAEB5F15Q42436884-7ABFFF44-D3CE-409C-862B-83DCAC3E7A41Q42952222-62B3E53E-AE6A-4AF5-BD9B-B3B7D6C3FF18Q42961033-7356DE8A-0106-4A71-AAF9-1A9644A4BEC9Q43252214-6A11A769-CE9F-4124-A7C0-61168B2D5894Q43653541-892FCFAF-1D61-4455-9D9B-4CFDFE825731Q44130291-3D6F7B1C-434B-480F-B4B5-B4D7FDCA89BCQ44488849-AECD133B-06D2-4CED-B432-FA9AC9BBEFADQ44688445-784DCDB7-B605-4D38-991E-7F59604CB5BDQ45014199-26489293-4EA1-47C8-AED7-54221188A53CQ45173573-0DB00E2D-0730-4226-AAF0-2864D1DB8EBCQ45950694-733F6CB8-758F-428E-A49A-85B2FA508D3AQ45968078-E02E5569-8290-41FA-A88D-3F1BFD064B85Q45969762-6B1ABB94-7A24-473D-8F24-110F9D975E8DQ47315179-421D751C-B11D-4ACA-922F-201179235964Q47352111-2518224A-7B97-4D5A-ADA8-97252CA46F0AQ48190240-50A5DFF0-C5BF-4447-B63B-159D63949A8EQ49896987-AD4B48CA-8269-4101-9F9F-88531B89B64AQ50105340-474B6C2F-77D1-467F-854F-B4FE5D75EE57Q50671083-EA82B03C-2BF3-4015-BAEA-4195396127C4Q50750458-29633C3A-4086-4854-A7B9-7FA9A5DA8248
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jocelyn Dupuis
@ast
Jocelyn Dupuis
@en
Jocelyn Dupuis
@es
Jocelyn Dupuis
@nl
Jocelyn Dupuis
@sl
type
label
Jocelyn Dupuis
@ast
Jocelyn Dupuis
@en
Jocelyn Dupuis
@es
Jocelyn Dupuis
@nl
Jocelyn Dupuis
@sl
prefLabel
Jocelyn Dupuis
@ast
Jocelyn Dupuis
@en
Jocelyn Dupuis
@es
Jocelyn Dupuis
@nl
Jocelyn Dupuis
@sl
P106
P31
P496
0000-0002-3193-1014